| Home | Log In | Register | Our Services | My Account | Contact | Help |
Mediwatch - Watch them rocket in 2005 !!! (MDW)
overgrowth
- 12 May 2005 22:21
|
Mediwatch is a small company destined to become a much bigger fish by the time this year is out. Mediwatch are already a market leader in urological medical diagnostics equipement and are currently exporting their products throughout the UK, Canada, Europe, India and Japan. That doesn't leave much of the globe left for them to capture - until you remember the good ol' US and China. These are the two massive markets which are destined to be added to MDW's export client portfolio by the end of 2005. |
|
|
The company is currently heavily undervalued. This is probably because Mediwatch's speciality is not a very glamourous business to be in as their equipment is used extensively to diagnose prostate cancer in men and other nasty urological conditions affecting both men and women. However, don't let that put you off investing in these guys. This is big business and is growing at an exponential rate as more and more people globally become health-aware as they get older. Mediwatch normally supply their products through to global markets via distribution agreements. They already have the best of distribution partners in the well known US medical distributor CR Bard who supply Canada and Europe and GE Medical who supply Japan. The UK business is handled by Mediwatch's own dedicated sales team. US FDA approval was gained for MDW's products at the start of last year, however a whole year of US legal wrangling meant that they were unable to seek a suitable partner for the crucial distribution agreement until the start of this year. This distribution agreement is expected by the board to have a "significant effect" on the share price so they are reluctant to give any clues as to when it will be signed, sealed and delivered. The general consensus is that this US distribution agreement will be announced in July/August. In China and Hong Kong, MDW have done things the other way round. They have set up distribution agreements with major Asian medical equipment distributors and have stock already out there waiting to sell into the markets - all they are waiting for is SDA approval (which is a "rubber stamp") from the Chinese authorities - this can take anything up to 12 months to come through and MDW applied during Autumn 2004 - so even more good news coming soon this year. Epidemiological data from British Association of Urology conference last year: On average 30-45% of all men between the age of 50 and 70 have at least one PSA test per year in the US / Italy / Australia. If that's not enough to convince you to invest a few hard earned coppers in MDW, they are also developing a PSA stick test product (PSAWatch) which is revolutionary and causing some excitement in medical circles. This product can also be adapted (at very low cost) for a whole spectrum of medical disciplines from Cardiology to Veterinary Practice! This product is likely to be released in the next few weeks. Philip Stimpson the CEO has said that this product is going to be their "gold mine" - I'm sure it will prove to be ours too. |
|
banjomick
- 29 Dec 2005 16:30
- 805 of 1497
banjomick
- 04 Jan 2006 00:37
- 806 of 1497
banjomick
- 04 Jan 2006 00:37
- 807 of 1497
Just been reading last months statement again,it does look very good,hopefully this months results will start to move us in the right direction for the rest of the year and beyond.
Apologies in advance if everyone has read this.....but it does look nice!
12th December 2005
British medical company announces FDA and CE approval on its new Multiscan product
Mediwatch UK Limited (AIM: MDW), the high-tech medical diagnostic equipment manufacturer and supplier has received FDA and CE approval on it's new Multiscan, a complete, portable urological diagnostic platform, providing clinicians with a variety of key measurements assessing bladder and prostate function.
These approvals will allow Mediwatch to sell the Multiscan into the USA, Europe and other countries around the world covered by these approvals.
With increasing life expectancy and an ageing population, prostate and bladder problems are among the fastest growing health concerns encountered by doctors today.
The ground-breaking MULTISCAN provides clinicians with mobile, real-time, ultrasound imaging, accurate measurement and organ volume calculation of the bladder, prostate and kidney.
Central component of a complete urological assessment system, the MULTISCAN can be a compact, all-in-one, stand alone diagnostic device or the main element of a diagnostic system, linking other devices which are manufactured by Mediwatch enabling clinicians to tailor investigations and improve patient throughput. Integrated Bluetooth enables wireless connectivity to facilitate state of the art communications and patient reports.
Said Mediwatch CEO Philip Stimpson "With the sales and marketing agreement signed with Medtronic Inc for the USA and other countries around the world obtaining FDA and CE approval is another milestone reached in the growth of our company where our technical expertise meets the demands of new screening techniques designed to diagnose disease areas at an earlier stage. Thus saving on costs hospitalisation and more importantly time, offering a better opportunity for an improved lifestyle for patients".
banjomick
- 04 Jan 2006 00:38
- 808 of 1497
The PSA Test is all we have at the moment with nothing to better it at the present time.
It has recently,over the last few years,been widely known that the PSA Test alone is not the answer but when used in conjuction with DRE and in conjuction with the individuals lifestyle/health,it is still a very important test and as said before all we have!
4. I'm very surprised at this article being highlighted so many times when looking through t'internet.....may be missing something but it's all old news re-formatted-imho
MDW's Multiscan is the centre of so many tests (in above announcement)which can be added to ie bought,to enable it to become a very powerfull bit of kit.....an all in one 'Near patient testing device'if you like.
My Father tells of (he manages to joke about it)going into local hospital for PSA test (every,think 3/4 months...)and seeing sad and worried men sat in waiting room waiting for results or deciding whether or not to have an operation and if so which one or in fact,not have one at all and see what happens!
MDW's 10 minute Prostate test (at the moment a test takes 7-10 days)that can be carried out in your local doctors surgery is a god send for all going through this terrible trauma.Cheaper and quicker results enable more tests to be carried out with more data obtained to give the specialist a better view of the actual state of the Prostate and along with the DRE will enable the correct decission for treatment.
Worth repeating again...As a CORUS worker we have always known about testicle cancer and how to check for lumps ect.Used to be nice on yearly medical if a young nurse wanted a feel for herself...alas no more...well no more young ones-lol.Last year on some course or other the head of medical dept.had a one hour
talk on health ect.and 10 minutes of that was on the Prostate and problems concerning it.This was a first for CORUS and was very impressed that i could get a PSA test when ever i liked.....scared at moment-lol.
PSA Testing is vital in deciding if an operation/treatment is required relating to the Prostate and MDW are or will be leading the way especially now with MDT backing,plus the Far East shortly (hopefully)
Excuse spelling....got excited after reading above announcement again!
***************************************************************************************
This is the article,by the way (read 4. above).
The reliability of a prostate cancer-screening test may be compromised by lifestyle and demographic factors, according to a new study published in the January 15, 2006 issue of CANCER
http://www.fightprostatecancer.org/site/News2?JServSessionIdr005=fauz0x1qq1.app1a&page=NewsArticle&id=6099&news_iv_ctrl=1001
banjomick
- 05 Jan 2006 00:30
- 809 of 1497
results in fewer deaths from the disease. Otherwise, he said,
you're identifying and treating cancers that didn't need to be
treated at all.The only way to tell for sure whether prostate
cancer screening prevents deaths from the disease is to
conduct a controlled experiment with thousands of men in
which half are randomly assigned to be screened and the
other half undergo a placebo procedure. Following those
men for a number of years would reveal whether there are
fewer deaths from prostate cancer in the screened group.
Such trials are now going on, Kramer said, and results
should be known in a few years. In the meantime, doctors
tend to recommend PSA testing with varying degrees of
enthusiasm based on their personal preferences. "I tell all my
male patients starting at age 40 they should get a PSA
because I believe in it," said Dr. Robert Nadler, associate
professor of urology at Northwestern University. "Anybody
you think is going to live 10 more years should get a PSA
test." Case by case basis
Dr. David Meltzer, associate professor of medicine at the
University of Chicago, said his message to patients is that
"it's a complicated personal decision."
Meltzer said it's "quite plausible"- though not yet proven -
that men might live longer if they were screened. But
"screening and treatment have consequences, like impotence
and incontinence and the discomfort of surgery."
So Meltzer suggests patients ask themselves what they
would do if the test came back positive and they were
subsequently diagnosed with cancer. If they would choose
not to undergo treatment--as about one-third of men do -
then having the test might just cause them unnecessary
anxiety.
"It's a set of decisions that requires a lot of discussion
between doctor and patient," Meltzer said. "These tests can
be very valuable for the right men, and they can be harmful
for the wrong men. The only way to know who's who is to
talk to them." Scientists are working to improve and refine
prostate cancer screening. Many doctors now believe
changes in PSA levels over time may be a more useful
indicator than a single PSA score. Jacqueline Strax, who
runs a prostate cancer support and information Web site
called PSA-Rising.com, says the PSA test is not perfect,
"but right now there's nothing better."
Strax believes the mobile screening van provides a valuable
service perhaps especially so for African-American men,
who have a higher risk of getting prostate cancer but are less
likely to get good medical care.
"Early detection allows men choices and control over the
course of their disease," said Strax, whose husband died of
prostate cancer. "Refusing to face the problem can make
things worse later."
http://www.manpros.org/2006/January/mpcsgjan06.pdf
banjomick
- 05 Jan 2006 00:30
- 810 of 1497
Annual PSA and digital rectal examination for men 50 years and older who have at least a 10 year life expectancy
Annual PSA and digital rectal examination for younger men who are of African-American descent or men with two or more first-degree relatives affected by prostate cancer
banjomick
- 05 Jan 2006 00:31
- 811 of 1497
If it's going to stay at 17p then we need to know more positives about the Medtronic (MDT) distribution deal within the results.
If it's going to take of,which is imminent after all,then we need to know more on PSAwatch or/and Far East distribution deals along with some info.from MDT themselves!
An announcement from MDT relating to the Multiscan (which is the Hub of MDW's products)is vital.The announcement,as said before,may be have been delayed to coincide with a total Urology strategy which may include other companies.
The Urology market is not by any means the main money generator as far as MDT is concerned,they mainly deal with Cardiac products but are expanding very rapidly to other fields.They have made it known that Urology is a key part of there future strategy in adding to their services,this has been seen by the distribution deal through Mediwatch (MDW).
The Multiscan is not that special unless you add the extras eg.PSA testing, then it becomes very very special.....so more upbeat news must follow soon.
All in my humble opinion of course but it does look very good for 2006....
banjomick
- 05 Jan 2006 01:12
- 812 of 1497
banjomick
- 05 Jan 2006 01:13
- 813 of 1497
banjomick
- 05 Jan 2006 01:23
- 814 of 1497
optomistic
- 05 Jan 2006 10:19
- 815 of 1497
Minder - 10 Jan 2006 10:25 - 816 of 1497
leedslad
- 10 Jan 2006 10:40
- 817 of 1497
Not long now!!
leedslad
- 10 Jan 2006 10:49
- 818 of 1497
brane - 10 Jan 2006 10:56 - 819 of 1497
leedslad
- 10 Jan 2006 11:47
- 820 of 1497
:-)
banjomick
- 12 Jan 2006 08:13
- 821 of 1497
http://news.bbc.co.uk/1/hi/health/4601858.stm
banjomick
- 12 Jan 2006 21:46
- 822 of 1497
http://www.bnn-online.co.uk/
banjomick
- 12 Jan 2006 22:37
- 823 of 1497
optomistic
- 13 Jan 2006 11:48
- 824 of 1497
| About MoneyAM | Ts and Cs | Privacy Policy | Investment Warning | Content Standards | Corporate Solutions | Advertise With Us | Site Map | © 2025 MoneyAM |
Follow us on Twitter